Admission Date:  [**2127-10-6**]              Discharge Date:   [**2127-10-15**]  Date of Birth:  [**2067-10-20**]             Sex:   F  Service: SURGERY  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 32612**] Chief Complaint: GI bleeding Pancreatic mass  Major Surgical or Invasive Procedure: [**2127-10-6**]: Successful embolization of a ruptured 4-mm GDA aneurysm, with four Cook coils.
CT here showing ruptured GDA artery aneurysm with hematoma compressing the CBD s/p IR embolization on a superior GDA aneurysm [**2127-10-6**].
Findings consistent with cirrhosis and portal hypertension including nodular heterogeneous liver, splenomegaly, varices and upper abdominal lymphadenopathy.
Interval placement of wall stent within the CBD, with expected pneumobilia.
Multiple chronic changes including cholelithiasis, simple periumbilical hernia, atherosclerotic disease, renal cysts.
Brief Hospital Course: 59F transferred from OSH with a 1 week history of epigastric pain, 24h of bloody stools, hypotension, tachycardia.
She was subsequently admitted to TICU s/p IR embolization of GDA.
Extubated without event that evening, and her foley was removed.
Ms. [**Known lastname **] was placed on CIWA/[**Doctor Last Name **] ativan for withdrawal symptoms and dilaudid for pain.
0n [**10-8**]: Patient underwent ERCP, single irregular stricture of malignant appearance that was 1.5 cm long was seen at the lower third of the common bile duct, cytology and pathology were sent, and a 60mm by 10FR Wallflex fully covered biliary stent was placed successfully in the main duct.
[**10-9**]: The cytology came back negative for malignant cells.
The patient was made NPO, antibiotics were started for ERCP induced pancreatitis.
She was transferred to the ICU, received 2 units of RBC and serial HCT was followed.
ERCP revealed bleeding from duodenal mass, epinephrine injections were applied for hemostasis.
There was ongoing oozing of blood after epinephrine injection.
[**10-13**]: HCT was stable.
Patient was transitioned to oral Dilaudid for pain control with IV breakthrough.
Knowing patient's substance abuse history, she underwent extensive teaching about appropriate use of narcotics pain medication prior discharge.
The patient verbalized understanding, she will follow up with her PCP [**Last Name (NamePattern4) **] [**2127-10-21**] to discuss needs to restart treatment with suboxone.
Medications on Admission: suboxone 36 tablets [**8-21**] 2.5 daily q 15 days gabapentin 800 mg tid; glipizide XL 10mg once daily simvastatin 20mg one tablety daily abilify 30mg daily in am   Discharge Medications: 1.
Aripiprazole 30 mg PO DAILY 2.
Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 3.
Gabapentin 300 mg PO TID 4.
GlipiZIDE XL 10 mg PO DAILY 5.
Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*2 6.
Senna 1 TAB PO BID:PRN constipation 7.
OxycoDONE (Immediate Release)  5-15 mg PO Q4H:PRN pain RX *oxycodone 5 mg [**1-21**] tablet(s) by mouth every four (4) hours Disp #*90 Tablet Refills:*0   Discharge Disposition: Home  Discharge Diagnosis: 1.
